Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 6 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Agios Pharmaceuticals Inc have a median target of 56.00, with a high estimate of 57.00 and a low estimate of 51.00. The median estimate represents a 0.83% increase from the last price of 55.54.
High | 2.6% | 57.00 |
Med | 0.8% | 56.00 |
Low | -8.2% | 51.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate | -1.91% |
Average growth rate | -9.37% |
More ▼
Revenue history & estimates in USD
Average growth rate | +5.14% |
Average growth rate | +20.23% |
More ▼